Neisseria elongata, a normal resident in the human oral cavity, rarely causes invasive infections. We herein report a case of endocarditis caused by Neisseria elongata subsp. nitroreducens that occurred in a patient without any apparent cardiac complications. The patient received aortic valve replacement following the administration of intravenous beta-lactam for five weeks. To our knowledge, this is the first published case in Japan of N. elongata infection in a patient without a prosthetic device.
Introduction
Neisseria elongata is an aerobic Gram-negative organism constituting part of the commensal flora of the human pharynx (1) . Unlike other organisms belonging to the genus Neisseria, N. elongata appears to be rod-shaped on Gram staining, potentially resulting in misidentification with other Gram-negative organisms. Several biochemical characteristics, including the capacity for catalase production, nitrate reduction and acid formation from D-glucose, can be used to differentiate the organism into three subspecies: N. elongata subsp. elongata, N. elongata subsp. glycolytica and N. elongata subsp. nitroreducens (2) . N. elongata is generally considered to be non-pathogenic; however, it occasionally causes serious infections, including bacteremia, septic arthritis and infective endocarditis (3) . In Japan, to our knowledge, only three cases of N. elongata infection, including prosthetic valve endocarditis in a child (4) , bloodstream infection seven years after valve replacement (5) and chronic infection of a prosthetic knee joint (6), have been published. We herein report a case of infective endocarditis caused by Neisseria elongata subsp. nitroreducens in a patient without any serious underlying diseases.
Case Report
A 78-year-old Japanese man came to the emergency room due to a fever lasting for one week. Oral clarithromycin, prescribed by his primary physician three days earlier, had moderately improved his symptoms. He also complained of chest discomfort that had developed approximately two hours prior to his visit but had disappeared on arrival. The patient had previously received treatment with candesartan cilexetil/hydrochlorothiazide for primary hypertension and dietary consultation for type 2 diabetes mellitus. He denied any recent dental procedures or use of illicit drugs.
On admission, the patient's blood pressure was 100/40 mmHg, his pulse rate was 79 beats per minute, his body temperature was 36.9 , his respiratory rate was 18 breaths per minute and his arterial oxygen saturation on room air was 97%. A physical examination revealed a diastolic murmur at the left sternal border. Neither mucocutaneous signs related to infective endocarditis, such as Janeway lesions, splinter hemorrhages, Osler nodes and conjunctival petechiae, nor active intraoral lesions were detected. Blood tests demonstrated leukocytosis (11,900/μL, neutrophils: 84%) and elevation of both serum creatinine (1.40 mg/dL) and C- The administration of meropenem (0.5 g every 8 hours) was started under an interim diagnosis of infective endocarditis of unknown etiology. No lesions suggesting the hematogenous dissemination of the organism were detected on computed tomography of the abdomen or magnetic resonance imaging of the brain. The antibiotic was subsequently switched to ceftriaxone (2 g every 24 hours) on day 5, as Gram-negative bacilli, suspected of being in the HACEK group and considered susceptible to the drug based on an MICroFAST4J assay (Siemens Healthcare Diagnostics, Deerfield, USA), grew in the two sets of blood cultures obtained on admission (Table 1 ). In contrast, a blood culture drawn on day 5 was negative. On day 21, ceftriaxone was changed to ampicillin (2 g every 8 hours) due to elevation of serum transaminases concurrently with the re-emergence of fever and deterioration of the patient's kidney function. TTE performed on day 20 demonstrated progression of the aortic valve regurgitation; therefore, the patient was transferred to another hospital, where he received ampicillin until day 34 and underwent aortic valve replacement on day 53. During the operation, perforation of the noncoronary cusp and destruction of the left coronary cusp were detected. However, the interventricular septum was intact, and the resected valve was culture-negative. The patient was subsequently discharged from the referred hospital on day 81 without sequelae. The Gram-negative bacilli recovered from the blood culture obtained on admission, which tested negative for catalase and positive for oxidase, were identified to be N. elongata with BD BBL CRYSTAL N/H (Becton Dickinson Japan, Fukushima, Japan). In order to confirm the production of acid from D-glucose and reduction of nitrate, organisms incubated on sheep blood agar overnight were heavily inoculated with Bacto Cystine Tryptic Agar (Becton Dickinson, Sparks, USA) supplemented with 1% D-glucose and N Bouillon (Eiken Kagaku, Nogi, Japan), respectively, and incubated at 35 for five days. Consequently, the organism reduced nitrate but did not produce acid from D-glucose. We finally identified the organism to be N. elongata subsp. nitroreducens based on these biochemical characteristics (Table 2). A 1,355-base pair sequence of the 16S ribosomal RNA gene of the organism, determined according to a previous description (7) 
Discussion
To the best of our knowledge, more than 20 cases of N. elongata endocarditis have appeared in the literature, of which 17, including the present case, fulfilled the modified Duke criteria for a definitive diagnosis of infective endocarditis (8) . Of the definitive cases, only half were associated with preexisting valvular complications, including valve replacement, prolapse and congenital defects ( Table 3 ). This finding shows that N. elongata, a generally less pathogenic organism, should be considered as a cause of endocarditis in patients without apparent cardiac disease.
Antecedent dental procedures and odontogenic infections are also considered to be risk factors for N. elongata endocarditis (9) . In contrast, reports of seven definitive cases, including the present case, excluded the presence of preceding intraoral complications (10) (11) (12) (13) (14) (15) . One study evaluating dental risk factors for infective endocarditis demonstrated that only 32.1% of patients infected with dental flora received dental procedures within the previous three months of hospital admission (16) , indicating that intraoral organisms often cause endocarditis, regardless of antecedent dental procedures. Hence, we speculate that, in the present case, the recovered N. elongata strain originally resided in the patient's oral cavity and entered the bloodstream during unrecognized oral events, such as daily dental care.
N. elongata subsp. nitroreducens is the subspecies recovered most frequently in cases of N. elongata endocarditis (Table 3) . Therefore, identifying the subspecies may be helpful for inferring whether the N. elongata recovered from normally sterile sites is truly pathogenic or rather a contaminant. Recently, homology of the 16S ribosomal RNA gene sequence has been utilized to identify various bacteria demonstrating ambiguous phenotypic results (17) . For example, this assay was used to determine the subspecies of recovered organisms in a few reports of N. elongata infection (4, 18). The 16S ribosomal RNA genes consist of approximately 1,500 base pairs. However, as for J2, the type strain of N. elongata subsp. glycolytica (19) , only one 1,355-base pair sequence of the gene has been deposited in databases (GenBank accession number: AJ239278). Therefore, in the present case, we compared 1,355-base pair sequences of the gene correspondingly truncated to the range of the deposited sequence of J2. Consequently, the sequences of the organism recovered in the present case and the type strains of the three N. elongata subspecies were found to be very close to each other. Instead, conventional methods utilizing biochemical reactions clearly determined the subspecies of the organism. Another report described the similar superiority of phenotypic differentiation to molecular assays in determining the subspecies of a recovered N. elongata strain (11) . Further studies are thus required to determine which assay is more appropriate for identifying subspecies of N. elongata. To date, drug susceptibility testing of N. elongata has not yet been standardized. However, this organism is generally considered to be susceptible to a wide range of antibiotics (20) . Most patients with N. elongata endocarditis are treated with beta-lactams, often in combination with aminoglycosides, for four to six weeks (9, 21) . In the present case, the administration of ampicillin and ceftriaxone, which inhibited the growth of the recovered organism at low concentrations (! 0.12 μg/mL and ! 0.125 μg/mL, respectively), was believed to be effective in controlling the patient's bacteremia. In contrast to the immediate improvement in the patient's general condition, the regurgitation of the affected valve worsened and valve replacement was required. A review of definitive or possible cases of N. elongata endocarditis showed that approximately half of the patients underwent surgical treatment (9) , with a similar frequency to that noted in an entire cohort of endocarditis cases (22) . In addition, N. elongata endocarditis occasionally results in serious complications, such as brain abscesses (9) and spondylodiscitis (10), although, to our knowledge, no deaths directly associated with N. elongata infection have been reported. These findings indicate that endocarditis caused by N. elongata should be managed with close follow-up. Furthermore, adequate therapies should be established with the further accumulation of cases.
In conclusion, the present case illustrates that N. elongata subsp. nitroreducens causes infective endocarditis in patients without apparent cardiac or dental risks. Further studies of the precise identification of subspecies and appropriate protocols for antibacterial treatment are needed.
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